PLSE — Pulse Biosciences Share News
0.000.00%
Last trade - 00:00- $1.97bn
- $1.90bn
- $0.35m
Brief: Pulse Biosciences Announces Positive Clinical Data On Nano-Pulse Stimulation Procedure For Low-Risk Basal Cell Carcinoma Lesions
U.S. STOCKS ON THE MOVE-Digital World Acquisition, Carnival, Crypto stocks
U.S. STOCKS ON THE MOVE-Arcutis Biotherapeutics, Chegg, Li Auto
Pulse Bio up as FDA clears device to treat skin disease sebaceous hyperplasia
Brief: Pulse Biosciences Announces FDA 510(K) Clearance For The Treatment Of Sebaceous Hyperplasia
Pulse Biosciences surges after naming new CEO, cutting jobs
Brief: Pulse Biosciences Announces Strategic Change Of Focus In Support Of Additional Opportunities For Medicinal Related Nano-Pulse Stimulation
Brief: Pulse Biosciences Reports Second Quarter 2022 Financial Results
Pulse Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Pulse Biosciences Inc expected to post a loss of 40 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-U.S. homebuilders, AMC Entertainment
U.S. STOCKS ON THE MOVE-Nikola, Coinbase, BridgeBio
Pulse Biosciences up as FDA approves expanded settings for skin device
Brief: Pulse Biosciences Receives FDA 510(K) Clearance Of Expanded Energy Settings For Use With The CellFX System
Brief: Pulse Biosciences, Inc. Announces Changes To Its Rights Offering
U.S. STOCKS ON THE MOVE-Bumble, Micron, Robinhood, Twitter
U.S. STOCKS ON THE MOVE-Twitter, Tesla, Duolingo
U.S. STOCKS ON THE MOVE-Twitter, Robinhood, Alibaba, Tesla
Brokerages downgrade Pulse Biosciences as skin device launch sputters